Data as of 3:59pm ET
| -0.07 / -4.35%|
The 2 analysts offering 12-month price forecasts for Neptune Technologies & Bioressources Inc have a median target of 7.35, with a high estimate of 8.07 and a low estimate of 6.62. The median estimate represents a +376.99% increase from the last price of 1.54.
The current consensus among 2 polled investment analysts is to Buy stock in Neptune Technologies & Bioressources Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.